EPO and perinatal asphyxia: Actually, in the clinical trials, erythropoietin showed neuroprotective effect against acute stroke [60], hypoxic-ischemic encephalopathy in newborns [61] and delayed ischemic deficits following aneurysmal subarachnoid hemorrhage [62].